estrogen biology research

Estrigenix Therapeutics, Inc. was formed in 2018 to develop and commercialize first-in-class therapeutics to treat and prevent hot flashes and dementia in post-menopausal women. It is a privately held pharmaceutical company working on a family of compounds to address menopause symptoms, moderating hot flashes and improving memory without the risks of breast cancer and stroke associated with traditional hormone replacement therapy, based on expertise in estrogen biology.

Read more

clinical trialsdrug discovery and developmentmedicinal chemistrypharmacology